

AI in Women's Health: from Diagnosis to Care
Women's health has longstanding gaps: delayed diagnoses, fragmented care, and conditions that are underrecognized, undertreated or inadequately researched. For example, perimenopause is so often missed or misdiagnosed, even though it affects millions of women at the peak of their careers. And many women with a condition like PCOS navigate care alone after they get diagnosed.
Join NXGN NYC for a panel and happy hour with an OB/GYN, two founders and a general manager building in women's health. They will talk about where AI can help with those gaps, where it has limits, and what it takes for a new tool to be used in real care.
Panelists
Brooke Davidson: board-certified OB/GYN with nearly 20 years of clinical practice. Clinical Assistant Professor at NYU Grossman School of Medicine and Strategic Advisor for Women's Health at Assort Health. Focus areas: perimenopause, menopause and mental health across the reproductive lifespan. brooke-davidson-do-facog
Dani Campillo Valencia: Co-Founder and CEO of femmli, a New York femtech company building a biosensor patch and AI app for continuous hormone monitoring, starting with perimenopause. Former Goldman Sachs. MIT Sloan MBA. Preparing femmli's first FDA pre-submission. danielacampillov
Marlo Garrison: General Manager at Nolla Health, the first company in the US to pilot fully autonomous prescribing in Utah. There she is developing the company's women's health offering. Background in clinical diagnostics and product development at Google. marlo-garrison
Jenny Westlund: Founder and CEO of Emmi Health, which supports women with hormonal conditions, starting with PMOS (PCOS). Biomedical engineer with a pharma and biotech career who built Emmi after her own PMOS diagnosis. jennywestlund
What we'll explore
🩺 Delayed diagnoses and fragmented care-- Where AI can help physicians and what still needs to be seen first
📈 Snapshots vs. continuous data-- Our current system manages women's health based on a single blood draw, a symptom questionnaire, and an appointment every few months, but hormones don't work that way. What changes when you can see the full pattern?
🧠 Mental health across the reproductive lifespan-- PMDD, postpartum depression and anxiety, and the menopause transition. Where could better screening and earlier support help?
🤝 After the diagnosis-- Many women navigate care alone once they have a diagnosis like PCOS. Where can AI and data help, and what are the limits of AI in care?
Event Format
6:00 PM: Doors open, happy hour and networking
6:30 PM: Panel discussion
7:15 PM: Audience Q&A
7:30 PM: Mingling
8:00 PM: Close
Who should attend?
Founders and operators building in women's health and femtech
Clinicians and healthcare professionals
Investors and advisors
Researchers and scientists
Students and early-career builders looking for the next opportunity
About NXGN:
NXGN is building a global community of next-generation leaders across healthcare and life sciences.
Since launching in the UK, NXGN has grown to 3,000+ members and hosted packed-out events in London and NYC, bringing together founders, physicians, operators, and investors.
Our mission is simple:
→ Fuel innovation
→ Foster mentorship
→ Create spaces where science, technology, and entrepreneurship collide
🌐 NXGN: https://nxgn.health/ 📬 Subscribe to the NXGN Substack for global updates and future events